Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page. This represents a minor platform update with no evident changes to the study details or page layout in the provided context.
    Difference
    0.0%
    Check dated 2026-05-18T19:14:22.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label was updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the study record.
    Difference
    0.0%
    Check dated 2026-04-27T08:08:15.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0 revision.
    Difference
    0.0%
    Check dated 2026-04-20T05:12:07.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed in the site’s release notes.
    Difference
    0.0%
    Check dated 2026-03-22T11:35:38.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This is a metadata/display change and does not affect study information or functionality.
    Difference
    0.0%
    Check dated 2026-03-08T02:00:11.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a new publication citation: Avapritinib improves cutaneous involvement in indolent systemic mastocytosis from the PIONEER study (J Am Acad Dermatol, online ahead of print).
    Difference
    0.0%
    Check dated 2026-02-21T17:02:40.000Z thumbnail image

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.